Page last updated: 2024-08-26

fibrinogen and Critical Illness

fibrinogen has been researched along with Critical Illness in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (9.30)18.2507
2000's5 (11.63)29.6817
2010's11 (25.58)24.3611
2020's23 (53.49)2.80

Authors

AuthorsStudies
Acevedo, V; Álvarez, P; Aroca, P; Carvajal, C; Cofré, F; Mackenney, J; Montes, V; Poli, C; Soto, V; Tapia, L; Verdugo, P1
Chen, Y; Hu, H; Li, C; Xia, W; Yao, X; Zhang, Y1
Cabrera-Garcia, D; Harrison, NL; Houck, PJ; Miltiades, A; Monteleone, M; Roh, D; Wagener, G1
Brandão, LR; Faustino, EVS; Hanson, SJ; Karam, O; Monagle, P; Parker, RI1
Abdullayev, R; Bilgili, B; Cinel, I; Gul, F; Seven, S1
Czempik, PF; Herzyk, J; Krzych, ŁJ; Wilczek, D1
Chen, M; Chen, S; Jiang, T; Si, S; Xia, Y; Yao, C; Zhang, G; Zhang, L; Zhang, X; Zhu, Y1
Brubaker, LS; Cebula, A; Cruz, MA; Lam, FW; Loor, M; Martinez-Vargas, M; Rosengart, TK; Rumbaut, RE; Seshadri, N; Yee, A1
Chen, M; Chen, S; Li, R; Sun, J; Sun, S; Xia, Y; Yao, C; Zhang, G; Zhang, L; Zhang, N1
Ahn, J; Albizua, I; Anderson, EJ; Arthur, CM; Bosinger, SE; Bowen, T; Chahroudi, A; Chandler, JD; Druzak, S; Fibben, KS; Geller, R; Iffrig, E; Ivanova, AA; Kim, SO; Kulpa, DA; Lam, WA; Liu, X; Maier, CL; Maner-Smith, K; Mosunjac, M; Ortlund, EA; Paiardini, M; Roback, JD; Roberts, AM; Roberts, BR; Rostad, CA; Sakurai, Y; Schneider, F; Silvestri, G; Stowell, SR; Verkerke, HP; Wong, AKH; Zhang, T1
Bai, T; Chen, C; Peng, T; Wang, L; Wu, X; Zhang, N; Zhang, T1
Guo, L; Hu, Y; Yang, X; Zeng, Q1
Gong, L; Huang, J; Li, X; Lu, X; Luo, T; Tang, M; Tang, Z; Xiao, Z; Xie, L; Yan, H; Yang, Y; Yao, Z; Zang, P; Zhang, X; Zheng, M; Zhu, D1
Arellano-Orden, V; Casado-Méndez, M; Díaz-Martín, A; Dusseck-Brutus, R; Fernandez-Pacheco, J; Leal-Noval, SR; Pastor de Las Heras, Á; Pérez-Torres, I; Rodríguez-Martorell, FJ1
Chow, JH; Galvagno, S; Grazioli, A; Herr, D; Madathil, R; Mazzeffi, M; Menaker, J; Menne, A; Rabin, J; Scalea, T; Tabatabai, A; Tanaka, K1
Dong, Y; Guo, W; Li, Y; Ma, X; Shi, D; Song, L; Xu, M; Zhang, X1
Jhang, WK; Park, SJ1
Altmayer, V; Cao, A; Demeret, S; Gallo, A; Le Guennec, L; Marois, C; Rohaut, B; Saheb, S; Weiss, N1
Besser, M; Bridgeman, C; Cox-Morton, S; Duff, E; Edwards, T; Hayman, M; Kirk, M; MacDonald, S; Mahajan, S; Moore, C; Sharp, M; Thomas, W; White, D; Williams, R1
Bonnin, P; Chousterman, BG; Delrue, M; Deye, N; Ketfi, C; Malissin, I; Mebazaa, A; Mégarbane, B; Neuwirth, M; Siguret, V; Stépanian, A; Voicu, S1
Alsobrooks, JP; Budnick, IM; Davis, JPE; Intagliata, NM; Konkol, SB; Lau, CE; Lisman, T; Northup, PG; Stotts, MJ; Sundararaghavan, A1
Bazine, M; Cholley, B; Clausse, D; Godier, A; Hamada, SR; Huche, F; Lang, E; Meslin, S1
He, Y; Meng, Z; Zhao, Y1
Dujardin, RWG; Juffermans, NP; Müller, MCA; Thachil, J; van Mierlo, G; Zeerleder, SS1
Bilker, WB; Coffin, SE; Fuchs, BD; Garrigan, C; Gerber, JS; Han, JH; Han, X; Kelly, BJ; Lautenbach, E; Nachamkin, I; Tolomeo, P; Wise, J1
Balakrishnan, A; Culler, CA; Guillaumin, J; Yaxley, PE1
Douka, E; Ekonomidou, F; Giamarellou, H; Karaiskos, I; Kokkoris, S; Routsi, C1
Bonnevier, J; Kander, T; Larsson, A; Schött, U; Tynngård, N1
Frechen, S; Frey, L; Fuhr, U; Holdt, LM; Maier, B; Scharf, C; Taubert, M; Vogeser, M; Zander, J; Zoller, M1
Artaud-Macari, E; Beduneau, G; Besnier, E; Buchonnet, G; Carpentier, D; Dehay, J; Girault, C; Grangé, S; Guerrot, D; Marchalot, A; Tamion, F1
Borggrefe, M; Dempfle, CE; Elmas, E; Kälsch, T; Lücke, T; Münch, E; Suvajac, N1
Jen, H; Shew, S1
Egi, M; Iwasaki, T; Kanazawa, T; Matsusaki, T; Morimatsu, H; Morita, K; Shimizu, K; Suzuki, S; Tani, M; Toda, Y; Wiedermann, CJ1
Armaganidis, A; Bonovas, S; Dimopoulou, I; Kopterides, P; Markatos, C; Orfanos, S; Rapti, E; Travlou, A; Tsangaris, I; Tsantes, AE1
Brand, K; Haubitz, M; Herget-Rosenthal, S; Kirsch, T; Mentes, E; Metzger, J; Mischak, H; Schiffer, E; Ulger, P; Weissinger, EM1
Ho, KM; Leonard, AD1
Hall, DP; Lone, NI; Stanworth, SJ; Walsh, TS; Watson, DM1
Gando, S; Hayakawa, M; Hoshino, H; Kubota, N; Oshiro, A; Sawamura, A1
Doberer, D; Dunkler, D; Fuhrmann, V; Funk, GC; Kneidinger, N; Lindner, G; Schneeweiss, B1
Lowe, GD; Pollock, JG; Rumley, A; Woodburn, KR1
Brudasca, I; Cucuianu, M; Stancu, A; Trif, I1
Boldt, J; Heesen, M; Hempelmann, G; Heyn, S; Müller, M1
Lawrie, AS; Machin, SJ; Mackie, IJ; McDonald, SJ; Purdy, G1

Reviews

1 review(s) available for fibrinogen and Critical Illness

ArticleYear
Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference.
    Pediatrics, 2022, 01-01, Volume: 149, Issue:1 Suppl 1

    Topics: Blood Coagulation Disorders; Child; Critical Illness; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; International Normalized Ratio; Multiple Organ Failure; Platelet Count; Severity of Illness Index

2022

Trials

4 trial(s) available for fibrinogen and Critical Illness

ArticleYear
Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Body Weight; Creatinine; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Female; Fibrin; Fibrinogen; Humans; Lactic Acid; Linezolid; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Prospective Studies; Respiratory Distress Syndrome; Risk Factors

2016
First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients.
    American journal of hematology, 2006, Volume: 81, Issue:12

    Topics: Adult; Aged; Anticoagulants; Antithrombin III; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Regression Analysis; Retrospective Studies; Time Factors

2006
Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 1995, Volume: 10, Issue:3

    Topics: Aged; Aged, 80 and over; Biomarkers; Blood Viscosity; Critical Illness; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Ischemia; Leg; Male; Middle Aged; Prospective Studies; von Willebrand Factor

1995
Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?
    Intensive care medicine, 1996, Volume: 22, Issue:7

    Topics: Adult; Critical Illness; Double-Blind Method; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Trauma; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Aggregation; Prospective Studies; Sepsis; Time Factors

1996

Other Studies

38 other study(ies) available for fibrinogen and Critical Illness

ArticleYear
Hematologic parameters and biomarkers predictors of severity in Multisystem Inflammatory Syndrome in children associated with SARS-CoV-2.
    Andes pediatrica : revista Chilena de pediatria, 2021, Volume: 92, Issue:3

    Topics: Biomarkers; C-Reactive Protein; Child; Clinical Deterioration; COVID-19; Critical Illness; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukocytes; Male; Neutrophils; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thrombocytopenia

2021
Prognostic value of fibrinogen to albumin ratios among critically ill patients with acute kidney injury.
    Internal and emergency medicine, 2022, Volume: 17, Issue:4

    Topics: Acute Kidney Injury; Albumins; Critical Illness; Fibrinogen; Humans; Intensive Care Units; Prognosis

2022
Insights into Fibrinogen-Mediated COVID-19 Hypercoagubility in Critically Ill Patients.
    Journal of neurosurgical anesthesiology, 2022, Jan-01, Volume: 34, Issue:1

    Topics: COVID-19; Critical Illness; Fibrinogen; Fibrinolysis; Humans; SARS-CoV-2; Tissue Plasminogen Activator

2022
Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study.
    Journal of intensive care medicine, 2022, Volume: 37, Issue:9

    Topics: Adsorption; Case-Control Studies; COVID-19; Critical Illness; Cytokines; Fibrinogen; Humans; Intensive Care Units; Retrospective Studies

2022
Hematologic System Dysregulation in Critically Ill Septic Patients with Anemia-A Retrospective Cohort Study.
    International journal of environmental research and public health, 2022, 05-29, Volume: 19, Issue:11

    Topics: Anemia; Blood Coagulation Disorders; Critical Illness; Fibrinogen; Humans; Intensive Care Units; Retrospective Studies; Sepsis

2022
Fibrinogen and antithrombin III are associated with in-hospital mortality among critically ill patients with acute kidney injury.
    Renal failure, 2022, Volume: 44, Issue:1

    Topics: Acute Kidney Injury; Anticoagulants; Antithrombin III; Cohort Studies; Critical Illness; Fibrinogen; Hospital Mortality; Humans; Prognosis; Retrospective Studies

2022
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation.
    Thrombosis research, 2023, Volume: 221

    Topics: COVID-19; Critical Illness; Extracellular Space; Fibrin; Fibrinogen; Hemostatics; Humans; Inflammation; Thrombosis; Vimentin

2023
Fibrinogen Is Associated with Prognosis of Critically Ill Patients with Sepsis: A Study Based on Cox Regression and Propensity Score Matching.
    Mediators of inflammation, 2023, Volume: 2023

    Topics: Critical Illness; Fibrinogen; Humans; Prognosis; Propensity Score; Retrospective Studies; Sepsis

2023
Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19.
    Nature communications, 2023, 04-04, Volume: 14, Issue:1

    Topics: Adult; Child; COVID-19; Critical Illness; Cytokines; Fibrinogen; Humans; SARS-CoV-2

2023
Effect of Microecological Regulator Combined with Enteral Nutrition on Immune and Coagulation Function in Patients with Chronic Critical Illness.
    Cellular and molecular biology (Noisy-le-Grand, France), 2023, Feb-28, Volume: 69, Issue:2

    Topics: Blood Coagulation; Chronic Disease; Critical Illness; Enteral Nutrition; Fibrinogen; Humans

2023
Factors affecting continuous renal replacement therapy duration in critically ill patients: A retrospective study.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2023, Volume: 27, Issue:5

    Topics: Acute Kidney Injury; Anticoagulants; Citrates; Citric Acid; Continuous Renal Replacement Therapy; Critical Illness; Fibrinogen; Heparin; Heparin, Low-Molecular-Weight; Humans; Renal Replacement Therapy; Retrospective Studies

2023
Proteomic Analysis of Pediatric Hemophagocytic Lymphohistiocytosis: a Comparative Study with Healthy Controls, Sepsis, Critical Ill, and Active Epstein-Barr virus Infection to Identify Altered Pathways and Candidate Biomarkers.
    Journal of clinical immunology, 2023, Volume: 43, Issue:8

    Topics: Biomarkers; Child; Complement Factor B; Critical Illness; Epstein-Barr Virus Infections; Fibrinogen; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Proteomics; Sepsis

2023
Relationship of thromboelastography and conventional clotting test values with severe bleeding in critically ill patients with coagulopathy: A prospective study.
    International journal of laboratory hematology, 2019, Volume: 41, Issue:5

    Topics: Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Cardiac Surgical Procedures; Critical Illness; Female; Fibrinogen; Hemorrhage; Humans; Intensive Care Units; International Normalized Ratio; Liver Failure; Male; Middle Aged; Partial Thromboplastin Time; Prospective Studies; Sensitivity and Specificity; Thrombelastography

2019
Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
    A&A practice, 2020, Volume: 14, Issue:7

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antithrombins; Betacoronavirus; C-Reactive Protein; Comorbidity; Coronavirus Infections; COVID-19; Critical Illness; Diabetes Mellitus; Dyslipidemias; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Obesity; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Protein C; Prothrombin Time; Renal Dialysis; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia

2020
Analysis of prediction and early warning indexes of patients with COVID-19.
    Expert review of respiratory medicine, 2020, Volume: 14, Issue:12

    Topics: Adult; Bilirubin; Biomarkers; Case-Control Studies; COVID-19; Critical Illness; Early Diagnosis; Female; Fibrinogen; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Retrospective Studies; SARS-CoV-2

2020
Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
    Thrombosis and haemostasis, 2020, Volume: 120, Issue:11

    Topics: Adolescent; Child; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Diseases; Hospital Mortality; Humans; Intensive Care Units, Pediatric; Male; Neoplasms; Platelet Count; Prothrombin Time; Retrospective Studies; Severity of Illness Index; Shock, Septic; Tertiary Care Centers

2020
Therapeutic plasma exchange in a critically ill Covid-19 patient.
    Journal of clinical apheresis, 2021, Volume: 36, Issue:1

    Topics: Aged; Albumins; C-Reactive Protein; Combined Modality Therapy; COVID-19; Critical Illness; Cytokine Release Syndrome; Fibrinogen; Humans; Interleukin-6; Male; Oxygen; Oxygen Inhalation Therapy; Plasma Exchange; Pneumonia, Ventilator-Associated; Respiration, Artificial; Respiratory Distress Syndrome; Salvage Therapy; SARS-CoV-2; Solutions

2021
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    International journal of laboratory hematology, 2021, Volume: 43, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Tests; COVID-19; Critical Illness; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Pandemics; Platelet Count; Retrospective Studies; SARS-CoV-2; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Young Adult

2021
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17

    Topics: Aged; Area Under Curve; Betacoronavirus; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Body Mass Index; Coronavirus Infections; COVID-19; Critical Illness; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Protein C; Protein S; ROC Curve; SARS-CoV-2; Venous Thromboembolism

2020
Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients.
    Thrombosis and haemostasis, 2021, Volume: 121, Issue:10

    Topics: Afibrinogenemia; Biomarkers; Blood Transfusion; Critical Illness; Down-Regulation; Esophageal and Gastric Varices; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Intensive Care Units; Liver Cirrhosis; Male; Middle Aged; Patient Admission; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2021
Major bleeding complications in critically ill patients with COVID-19 pneumonia.
    Journal of thrombosis and thrombolysis, 2021, Volume: 52, Issue:1

    Topics: Aged; Anticoagulants; Biomarkers; Blood Coagulation; COVID-19; Critical Illness; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome

2021
Fibrinogen Level Predicts Outcomes in Critically Ill Patients with Acute Exacerbation of Chronic Heart Failure.
    Disease markers, 2021, Volume: 2021

    Topics: Aged; Aged, 80 and over; Biomarkers; Critical Illness; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome

2021
The relation between fibrinogen level, neutrophil activity and nucleosomes in the onset of disseminated intravascular coagulation in the critically ill.
    Journal of internal medicine, 2021, Volume: 290, Issue:4

    Topics: Critical Illness; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Neutrophils; Nucleosomes; Thrombocytopenia

2021
Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis.
    Critical care medicine, 2018, Volume: 46, Issue:7

    Topics: Aged; alpha-Macroglobulins; Biomarkers; C-Reactive Protein; Cohort Studies; Critical Illness; Ferritins; Fibrinogen; Haptoglobins; Hospital Mortality; Humans; Male; Middle Aged; Predictive Value of Tests; Procalcitonin; Sepsis; Serum Amyloid A Protein; Serum Amyloid P-Component; Tissue Plasminogen Activator

2018
Clinical use of cryopoor plasma continuous rate infusion in critically ill, hypoalbuminemic dogs.
    Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2019, Volume: 29, Issue:3

    Topics: Animals; Critical Care; Critical Illness; Dog Diseases; Dogs; Factor VIII; Female; Fibrinogen; Hypoalbuminemia; Infusions, Intravenous; Male; Retrospective Studies; Serum Albumin

2019
High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation Disorders; Critical Illness; Female; Fibrinogen; Humans; Male; Middle Aged; Minocycline; Partial Thromboplastin Time; Tigecycline

2015
Comparison of point-of-care hemostatic assays, routine coagulation tests, and outcome scores in critically ill patients.
    Journal of critical care, 2015, Volume: 30, Issue:5

    Topics: Aged; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Critical Care; Critical Illness; Female; Fibrinogen; Hemostasis; Humans; Intensive Care Units; Male; Organ Dysfunction Scores; Partial Thromboplastin Time; Platelet Count; Point-of-Care Systems; Prognosis; Prospective Studies; Thrombelastography

2015
The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
    Critical care medicine, 2016, Volume: 44, Issue:11

    Topics: Aged; Biomarkers; Critical Illness; Female; Ferritins; Fibrinogen; France; Hospital Mortality; Humans; Intensive Care Units; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Male; Megakaryocytes; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Sensitivity and Specificity; Sepsis; Simplified Acute Physiology Score; Thrombocytopenia

2016
Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008, Volume: 19, Issue:8

    Topics: Biomechanical Phenomena; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Critical Illness; Elastic Modulus; Fibrinogen; Hemostasis; Humans; Platelet Count

2008
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
    Journal of pediatric surgery, 2008, Volume: 43, Issue:12

    Topics: Blood Component Transfusion; Critical Care; Critical Illness; Factor VIIa; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant; Male; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Venous Thrombosis

2008
Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:4

    Topics: Adult; Aged; Algorithms; Antithrombins; Biomarkers; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Intensive Care Units; Japan; Logistic Models; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Prothrombin Time; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Time Factors

2009
The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Critical Illness; Factor V; Factor XIII; Female; Fibrinogen; Genotype; Hemostasis; Humans; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prospective Studies; Sepsis; Shock, Septic; Young Adult

2010
Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury.
    Kidney international, 2010, Volume: 78, Issue:12

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Albumins; alpha 1-Antitrypsin; beta 2-Microglobulin; Biomarkers; Cohort Studies; Collagen Type I; Critical Illness; Female; Fibrinogen; Humans; Intensive Care Units; Longitudinal Studies; Male; Middle Aged; Peptides; Prognosis; Proteomics; Sensitivity and Specificity

2010
Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study.
    Anaesthesia and intensive care, 2011, Volume: 39, Issue:1

    Topics: Acidosis; Adult; Aged; Blood Platelets; Blood Transfusion; Calcium; Cohort Studies; Critical Illness; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Hypocalcemia; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Severity of Illness Index

2011
Factors associated with prophylactic plasma transfusion before vascular catheterization in non-bleeding critically ill adults with prolonged prothrombin time: a case-control study.
    British journal of anaesthesia, 2012, Volume: 109, Issue:6

    Topics: Aged; Bilirubin; Blood Component Transfusion; Case-Control Studies; Catheterization, Central Venous; Catheterization, Peripheral; Cohort Studies; Critical Care; Critical Illness; Erythrocyte Transfusion; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Plasma; Platelet Count; Prospective Studies; Prothrombin Time; United Kingdom

2012
Acute phase proteins do not account for unmeasured anions in critical illness.
    European journal of clinical investigation, 2007, Volume: 37, Issue:10

    Topics: Acid-Base Equilibrium; Acid-Base Imbalance; Adult; Aged; Anions; Blood Gas Analysis; C-Reactive Protein; Carbon Dioxide; Computer Simulation; Critical Illness; Data Interpretation, Statistical; Female; Fibrinogen; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Predictive Value of Tests; Prospective Studies

2007
Clinical studies on plasma protein C. Correlation with serum cholinesterase.
    Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cholestasis; Cholesterol; Cholinesterases; Critical Illness; Female; Fibrinogen; Humans; Hypertriglyceridemia; Liver Cirrhosis; Male; Middle Aged; Nephrotic Syndrome; Obesity; Protein C; Triglycerides

1993
Prothrombin time derived fibrinogen determination on Sysmex CA-6000.
    Journal of clinical pathology, 1998, Volume: 51, Issue:6

    Topics: Animals; Anticoagulants; Critical Illness; Fibrinogen; Hemoglobinopathies; Humans; Kidney Diseases; Liver Diseases; Prothrombin Time; Rabbits; Reference Values; Statistics, Nonparametric

1998